Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : JMAR Technologies(JMAR) -- Ignore unavailable to you. Want to Upgrade?

To: timwa who wrote (7919)	5/8/1999 3:53:00 PM
From: Bilberry	Read Replies (2) \| Respond to of 9695

No, I am saying that they are putting the resources into the projects that have the most promise. That is why they got rid of Surgilase years ago, and cut out other low margin businesses. The x-ray sources should have the highest margins of any product that they have ever produced since it is one of a kind in the world. That is where I want to see them putting their money and resources. If some of the brightlight applications are not as promising, then I would say put the limited resources into x-ray instead. Keep in mind that JMAR is not a cash vault with unlimited resources. Now a joint venture with a major company would change the whole ballgame. And I would expect that to happen sometime in the next year or two as the applications of x-ray far outstrip JMAR's resources, so they must prioritize the applications. I think XRL is the primary application that they are concentrating on currently, but there are dozens of other applications (Like Tomography). Perhaps a strategic partner for each application would be a good idea. What do you think? --Bilberry